Leaving the study early · patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Leaving the study early · patients with antipsychotic‐induced tardive dyskinesia
It is very uncertain whether specific antipsychotic changes acceptability of the treatment: leaving the study early compared with other drugs (very low certainty).
1 finding from 1 review
Leaving the study early · female and male 42 (mean) years old patients with schizophrenia or schizoaffective disorder and antipsychotic‐induced tardive dyskinesia
It is very uncertain whether reduced dose of antipsychotics changes acceptability of the treatment: leaving the study early compared with antipsychotic maintenance (very low certainty).
1 finding from 1 review
RR 0.33 [0.06, 1.99]
1 study · 8 participants
Very low
Acceptability (number of participants lost to post‐treatment assessment) · patients with depression
It is very uncertain whether mindfulness‐based 'third wave' cognitive and behavioural therapies changes treatment acceptability at post‐treatment Dropout rates compared with other psychological therapies (very low certainty).
1 finding from 1 review
Patient acceptability of treatment and its side effects · Adults with chronic periodontitis
The review found no eligible studies for this question.
1 finding from 1 review
Patient acceptability of treatment and its side effects · Adults with chronic periodontitis
The review found no eligible studies for this question.
1 finding from 1 review
Secondary outcome: acceptability of treatment
1 finding from 1 review
Secondary outcome: acceptability of treatment
1 finding from 1 review
Acceptability ‐ total dropouts · adults with Major Depressive Disorder
Ketamine showed no clear difference in acceptability: total dropouts№ of participants: 72(1 RCT) compared with midazolam (low certainty).
1 finding from 1 review
OR 0.33 [0.05, 2.09]
Studies not reported
Low
Acceptability ‐ total dropouts · participants with panic disorder
It is very uncertain whether rTMS + pharmacotherapy changes acceptability: dropouts for any reason number of dropouts compared with sham rTMS + pharmacotherapy (very low certainty).
1 finding from 1 review
Adverse effects (tongue trauma, nausea) and acceptability · Adults (over 18 years) with a clinical or self-assessed diagnosis of halitosis
1 finding from 1 review
Withdrawals due to adverse events · adults (aged 18 years+) with depression in bipolar disorder
1 finding from 1 review
Secondary outcome: acceptability of treatment · skin changes caused by nerve damage in leprosy
1 finding from 1 review
Acceptability ‐ total dropouts · schizophrenia
It is very uncertain whether adjunctive lithium + antipsychotics changes acceptability of treatment leaving early due to any reason compared with placebo/no adjunctive treatment + antipsychotics (very low certainty).
1 finding from 1 review
Acceptability ‐ total dropouts · schizophrenia
Lithium as sole treatment showed no clear difference in acceptability of treatment leaving early due to any reason compared with placebo (low certainty).
1 finding from 1 review
Acceptability ‐ total dropouts · schizophrenia
It is very uncertain whether lithium changes acceptability of treatment leaving early due to any reason compared with antipsychotics (very low certainty).
1 finding from 1 review
Acceptability ‐ total dropouts · adults with Major Depressive Disorder
Esketamine showed no clear difference in acceptability: total dropouts№ of participants: 773(5 RCTs) compared with placebo (moderate certainty).
1 finding from 1 review
OR 1.58 [0.92, 2.73]
Studies not reported
Moderate
Acceptability ‐ total dropouts · adults with Major Depressive Disorder
It is very uncertain whether ketamine changes acceptability: total dropouts№ of participants: 201(6 RCTs) compared with placebo (very low certainty).
1 finding from 1 review
OR 1.25 [0.19, 8.28]
Studies not reported
Very low
Dropout · women of any age, with PND up to 12 months
It is very uncertain whether antidepressants changes treatment acceptability ‐ dropouts (early phase, < 5 weeks) compared with treatment (very low certainty).
1 finding from 1 review
RR 1.71 [0.91, 3.23]
Studies not reported
Very low
Withdrawals due to adverse events · adults (aged 18 years+) with depression in bipolar disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found